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High-speed Analysis of Large Sample Sets –How






New advances in laser-based
MS with respect to analytical
depth, signal robustness and
sample flexibility in combination
with its intrinsically high sample
analysis speed can fill many of
the gaps in the field of proteo-
mics that can currently only be
served with severe limitations
by the commonly employed but
much slower ESI-based proteo-
mic tools, thus arguably allow-
ing for the analysis of 1M
samples/day on a single plat-





 Future proteomic analyses for longitudinal studies and P4 medicine arguably require 1M samples/
day.
 Proteome depth/coverage is commonly the focus whereas analytical speed is typically neglected.
 A compromise between analytical depth and speed is needed for future large-scale studies.
 Ultrahigh-speed ‘omic’ analyses require tools that are intrinsically fast such as laser-based MS.
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High-speed Analysis of Large Sample Sets –
HowCan This Key Aspect of the Omics Be
Achieved?
Rainer Cramer*
High-speed analysis of large (prote)omics sample sets at
the rate of thousands or millions of samples per day on
a single platform has been a challenge since the beginning
of proteomics. For many years, ESI-based MS methods
have dominated proteomics because of their high sensi-
tivity and great depth in analyzing complex proteomes.
However, despite improvements in speed, ESI-based MS
methods are fundamentally limited by their sample intro-
duction, which excludes off-line sample preparation/frac-
tionation because of the time required to switch between
individual samples/sample fractions, and therefore being
dependent on the speed of on-line sample preparation
methods such as liquid chromatography. Laser-based
ionization methods have the advantage of moving from
one sample to the next without these limitations, being
mainly restricted by the speed of modern sample stages,
i.e. 10ms or less between samples. This speed matches
the data acquisition speed of modern high-performing
mass spectrometers whereas the pulse repetition rate
of the lasers (>1kHz) provides a sufficient number of
desorption/ionization events for successful ion signal
detection from each sample at the above speed of the
sample stages. Other advantages of laser-based ioniza-
tion methods include the generally higher tolerance to
sample additives and contamination compared with ESI
MS, and the contact-less and pulsed nature of the laser
used for desorption, reducing the risk of cross-contami-
nation. Furthermore, new developments in MALDI have
expanded its analytical capabilities, now being able to
fully exploit high-performing hybrid mass analyzers and
their strengths in sensitivity and MS/MS analysis by gen-
erating an ESI-like stable yield of multiply charged analyte
ions. Thus, these new developments and the intrinsically
high speed of laser-based methods now provide a good
basis for tackling extreme sample analysis speed in the
omics.
The “omics”, in particular proteomics, have tremendously
benefited from the arrival of modern MS with its unrivaled
performance in sensitivity while providing high specificity and
superior multiplexing because of its exquisitely high resolu-
tion in mass separation. Simultaneous and accurate detec-
tion of numerous forms of biomolecules is easily achievable
in one MS experiment. This biomolecular detection sensitivity
has been exploited and further improved over the years, also
in combination with up-stream sample fractionation methods,
lowering the limits of detection and expanding the number of
identified and quantified proteins as well as other biomole-
cules (metabolites, lipids, etc.). It has led to a race for higher
proteome coverages with records being frequently broken as
exemplified by work in the areas of phosphoproteomics (1–5)
and blood plasma proteomics (6–8).
The invention and commercial manufacturing of ever
newer and faster mass spectrometers were crucial for these
advances into the depth of many proteomes. Orbitrap tech-
nology (9, 10) and ion mobility spectrometry (11, 12) are
good examples of novel concepts of ion manipulation that
supported this development. In combination with faster MS/
MS and ion detection as well as faster signal readouts and
new MS/MS strategies such as data-independent acquisition
(DIA) (11, 13) higher proteome coverages have been obtained
at increasing speed. In addition, further improvements in pro-
tein labeling methods (e.g. greater multiplexing (14)) and sep-
aration techniques (e.g. UHPLC (15, 16)) have helped to
speed up the analysis of complex samples (17). Thus, new
MS hardware and methods as well as advances in up-stream
separation/fractionation techniques have arguably resulted in
fast large-scale proteomics.
However, the impact of these advances are greatest for in-
depth proteomics and the analysis of extensively processed
samples that often undergo complex sample preparation pro-
tocols (1, 6, 11). These protocols typically rely on (nano)
HPLC separation and frequently on further up-stream sample
purification/extraction such as filter-aided sample preparation
and can take a minimum of 3days from proteolytic digestion
to data evaluation (11). For the analysis of sub-proteomes,
these protocols can be even more complex, including protein
depletion if there is a large protein abundance range such as
in blood (6), or specific peptide/protein enrichment by affinity
purification as it is the case in phosphoproteomics (1). For
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obvious reason, such thoroughly prepared samples are
somewhat limited in numbers, simply by the fact that these
are prepared in specialized laboratory, of which there are
only a few in existence.
Some of the latest advances in deep proteome analysis
now allow the confident identification of .10 (HeLa cell line)
proteomes per day at a depth of nearly 8000 identified pro-
teins using TMT labeling/multiplexing (4) whereas new data
mining software based on neural networks can substantially
improve the number of confident precursor peptide identifi-
cations within a DIA bottom-up proteomics analysis approach
(18). Both strategies easily lead to an in-depth analysis (.5000
proteins; .50,000 peptide precursors) of 10–20 (HeLa) pro-
teomes per day on a single MS instrument. Further improve-
ments in this area can be expected and one day might allow
the analysis of 100 or more proteomes per day, though in the
near future most likely only at the expense of proteome
coverage.
However, there seems to be no major movement toward
extremely fast omic analysis of several samples per seconds
for extremely large sample sets, i.e. millions or even billions
of samples, despite the realization that baseline abundances
of specific proteoforms or other biomolecular species can
substantially vary among (healthy) individuals, in particular in
the human population (19–21), and thus for diagnostic pur-
poses ultimately demanding frequent longitudinal sampling of
all individuals in a given population. Only this type of large-
scale sampling and subsequent (prote)omic analysis will pro-
vide the much-needed data for advancing the understanding
of population-wide proteome changes and exploiting protein/
proteome analysis for improved diagnostics and therapeu-
tics. For population-wide preventive medicine, frequent meas-
urements of an individual’s proteome (or subsets of it) will be
the next crucial step in clinical proteomics with the potential to
fulfill the promises of the much-heralded future of personalized
and precision medicine.
Unfortunately, the scale and speed for this type of pro-
teomics is far from achievable with the analytical tools cur-
rently employed, especially with those for in-depth pro-
teome analysis. Thus, it seems reasonable to consider a
departure from exclusively focusing on these tools and the
quest for comprehensiveness.
Regarding MS-based methods, the coupling of slow sepa-
ration/fractionation methods such as chromatography to ESI
has served the first decades of proteomics well. Many pro-
teomes have been qualitatively and (to a lesser) extent quan-
titatively catalogued and compared in depth, though typically
only from a few biological replicates and time points as the
price for in-depth analysis are analysis times of hours, at the
best tens of minutes per sample (18). Even multiplexing using
current labeling methodologies cannot provide the means for
the analysis of millions, let alone billions of samples per day.
Consequently, the low speed of up-stream sample fractio-
nation and ESI need to be addressed. With respect to ESI, a
handful of groups have considered improvements of its sam-
ple introduction and thus sample-to-sample speed. These
efforts have led to sample analysis rates of seconds per sam-
ple (22, 23), in some cases even up to 6 samples per second,
though with the caveat of a relatively convoluted (micro)flu-
idic sample introduction system (24). However, the latter
proof-of-principle study was shown with the small drug mole-
cule dextromethorphan and its primary metabolite dextro-
rphan rather than with peptides or proteins as analytes.
Although up to 6 samples per second is extremely fast com-
pared with conventional ESI MS analysis, it could well be its
limit, given the practical difficulties of rapidly changing sam-
ples and achieving a stable electrospray in this time frame.
Fortunately, there are other (soft) ionization methods in
MS that are well suited for fast sample turn-over rates.
These methods typically benefit from the off-line prepara-
tion of samples on a stage that can be moved from sample
to sample at extreme speed. Ionization of these samples
can be achieved by either scanning over the samples using
FIG. 1. Comparison of reported sam-
ple analysis speeds for various peer-
reviewed high-speed MS approaches.
Please note that the size of each circle
does not accurately reflect the exact
analysis speed for each MS approach.
AP: atmospheric pressure; VS MALDI:
vacuum solid MALDI; DESI: desorption
electrospray ionization; LDTD: laser diode
thermal desorption.
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continuous ionization methods (e.g. DESI(25)) or equally fast
pulsed ionization methods (e.g. SAWN (26), AMI (27)). Fig. 1
provides a comparison of sample analysis speeds for various
reported high-speed MS approaches.
The ultimate tools for fast ionization are lasers with their
well-defined beams and stable energy output, providing
nanosecond or shorter pulses of high energy focused onto a
small desorption area. Lasers can provide soft ionization
events at high repetition rates (.1 kHz) with sufficient ion
yield from a single laser shot. Thus, in laser-based MS the
time to analyze a sample is ultimately limited by the speed of
the sample stage and the mass analyzer. Currently, these
devices allow analysis times of 10-50ms or less per sample,
i.e. 20–100 data acquisitions (samples) per second or up to
8.6 million samples per day. This rough calculation assumes
continuous sample supply as might be possible using a con-
veyor belt set-up. However, the up-stream and on-line nature
of using conveyor belt technology would realistically require
several sample preparation stations along the conveyor belt
with all the disadvantages of a complex on-line multi-station
up-stream sample preparation system. A more practical sce-
nario is the use of microtiter plates as a standard format,
which provides a truly off-line and scalable sample prepara-
tion system that can be set up with the required number of
commercial sample preparation stations needed for feeding
the mass spectrometer at the applicable sample throughput.
In this case, additional time for changing plates needs to be
added. Using modern robotics, microtiter plates can be easily
changed within 5 s, and with formats of high sample density
such as 1536-well microtiter plates, rates of ;6.5 million
samples analyzed per day should be feasible on one laser-
based MS instrument. Roughly 1000-2000 of these analytical
platforms would therefore be sufficient for analyzing 1 sample
per human being per day.
Data transfer, processing and further mining at these high
data acquisition speeds might then arguably present the next
challenge, which will also depend on the exact use of meta-
data and database searching. Even more challenging will be
the logistics behind individual sample collection and delivery
to the laboratory at this scale. Interestingly, these questions
have recently become highly topical as part of the COVID-19
testing response and calls for developing future delivery sys-
tems such as small drone deliveries (cf. UK Research and
Innovation’s Future Flight Challenge).
A maximum sample analysis rate of 100 samples per sec-
ond is typically based on the acquisition of MS profiles with-
out any subsequent MS/MS data collection. Depending on
the exact requirements, such as the desired depth of analy-
sis, this rate can obviously be reduced by any factor, thus
allowing MS/MS experiments to be carried out on precursor
ions of interest in the acquired MS profile. For example,
reducing the sample analysis rate from 100 to 10 samples
per second would allow the MS/MS analysis of 9 precursor
peptide/protein ions from the acquired MS profile. For com-
plex proteome samples, pre-fractionation might also be de-
sirable and the possible 100 MS (or MS/MS) data acquisi-
tions might be used on 20 proteome fractions each being
analyzed by one precursor ion scan/profile and 4 subsequent
MS/MS analyses per precursor ion profile. In this simple
data-dependent acquisition (DDA) scenario, 80 precursor
ions could be identified by MS/MS sequencing in 1 s or up to
80,000 in 1000 s or less than 17min. Using a DIA analysis
strategy, 500 LC fractions of a digest mixture from one pro-
teome sample could be analyzed by switching continuously
between MS and MS/MS data acquisition, resulting in 1000
data acquisitions that require only 10s of analysis time. With
a 2-kHz laser each data acquisition can benefit from 10–20
individual desorption events, which in the case of MALDI
only consume a fraction of the peptide amount in each LC
fraction but are sufficient for the analysis of low femtomole
amounts of peptides. These examples clearly demonstrate
that in-depth proteome analysis can also benefit from the
speed of laser-based ionization with the additional advant-
age of enabling much greater sample analysis speed if less
depth can be tolerated.
Platforms using pulsed lasers are also ideal set-ups for
avoiding cross-contamination or carry-overs from previous
samples as lasers provide the necessary desorption energy
in a contact-less way with the desorption/ionization events
being discrete and shorter in time (nanoseconds) than the
time it takes to move from one sample to the next. Thus,
laser-based ionization techniques are ideal for rapid, highly
controllable desorption/ionization for MS analysis.
An important feature of all these techniques is off-line sam-
ple preparation, allowing the use of multiple sample prepara-
tion stations as feeder devices to the analytical MS system.
Thus, up-stream bottlenecks reducing the ultimate sample
analysis speed can be easily avoided and the speed in sam-
ple analysis will roughly increase with the number of off-line
sample preparation platforms. Off-line sample preparation
also provides greater flexibility regarding specific require-
ments in sample preparation and enables easier adaptation
of new sample preparation methods and their associated
instrumentation.
Nonetheless, given current performance data, moving
away from ESI- to laser-based MS analyses for greater speed
is likely to lead to a loss of overall sensitivity, even if the
same or a similar sample pre-fractionation methods were
employed and MALDI was used as the softest and most sen-
sitive laser-based ionization technique (28, 29). For proteo-
mics analysis, ESI-based methods are currently the most
sensitive, providing the greatest proteome coverages, partic-
ularly in combination with on-line LC separation. However,
compared with ESI, MALDI has competitive advantages in
three important analytical areas, namely scalability, speed,
and sample flexibility. Sample flexibility, i.e. flexibility with
regard to the overall sample conditions, is important if these
conditions need to be adjusted to provide an optimal
High-Speed Analysis of Large Sample Sets
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environment for the analyte to be ionized and detected, or
equally important, if sample conditions are sub-optimal but
would take a lot of time to ‘clean up’ for best ionization
results. The latter would have a direct impact on the time
needed for sample preparation. In combination with the
advantages in scalability, which are partially a result of off-
line sample preparation, and speed (because of the above-
mentioned laser characteristics), MALDI is ideal for high-
speed biomolecular analysis of extremely large sample sets.
Taking its good performance in low-speed in-depth proteo-
mic analysis (and MS imaging) into account MALDI is prob-
ably the most versatile proteomic tool.
A relative comparison of the analytical performance of ESI,
DESI, (conventional solid-state) MALDI and liquid AP-MALDI
in six important areas (sensitivity, scalability, speed, signal sta-
bility, sample flexibility, and structural elucidation) is shown in
Fig. 2.
Employing MALDI instead of ESI and exploiting its capabil-
ities in high-speed MS profiling of large sample sets,
undoubtedly results in a reduction of the number of biomole-
cules that will be detected. Nevertheless, recent develop-
ments have shown that fast MALDI MS profiling has gained
further depth. The use of heated atmospheric pressure (AP)
ion sources on hybrid mass analyzers and liquid MALDI sam-
ple preparation methods that facilitate the production of mul-
tiply charged proteinaceous analyte ions have significantly
contributed to these developments (30). The combination of
these recent advances that add additional functionalities to
(prote)omic profiling by MALDI MS, which in its earlier form
was significantly less-advanced and ultimately unsuccessful
in accurate disease diagnostics (cf. SELDI (31)), could soon
become sufficiently sensitive for the detection of important
peptide/protein panels and other molecular biomarkers that
can be further exploited for clinical diagnostics as well as for
understanding the underlying (systems) biology (30). Some of
the earlier shortcomings of MALDI MS(/MS) profiling such as
poor biomarker identification/verification from the same sam-
ple can now be addressed at greater speed, enabling rapid
analysis of large sample sets together with a meaningful level
of depth in (prote)omic biomarker detection. These newly
gained advances in (bio)molecular detection at high speed
also provides additional power and flexibility in devising
large-scale nonclinical (prote)omic analyses, including com-
pound library screening in biopharmaceutical research and
environmental screening at extreme speed (32–34).
Furthermore, liquid AP-MALDI MS as one of the newly
introduced MALDI MS approaches has the potential to offer
kinetics measurements, e.g. of enzymatic reactions, on target
and in real time within the mass spectrometer because of the
liquid state of the MALDI sample (35). In general, liquid
MALDI samples provide greater flexibility for creating specific
sample conditions (e.g. through a greater choice of additives)
that are desirable for certain types of analytes/analyses but
are not achievable with solid MALDI samples or are incom-
patible with other liquid-based ionization techniques such
as ESI (36, 37). One prominent example is the use of
FIG. 2. Relative comparison between
ESI, DESI, MALDI, and liquid AP-MALDI
with respect to their MS performance in
six analytical areas (sensitivity, scalability,
speed, signal stability, sample flexibility,
and structural elucidation) on a scale
from 0 (center; lowest performance in bio-
molecular detection) to 10 (outer line; best
performance in biomolecular detection).
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trifluoroacetic acid (TFA), which has been abandoned in LC-
ESI MS/MS proteomic analysis because of its incompatibility
with ESI. Ryumin et al. have shown in an LC-MALDI MS/MS
study of protein digests that liquid MALDI can tolerate the
use of TFA, providing the same protein sequence coverage
and performance as formic acid (37). In the same study,
other useful advantages of liquid MALDI were demonstrated
such as the low consumption of the prepared MALDI sample,
potentially allowing the recovery of most of the digest (argu-
ably up to 99%). Furthermore, medium- to long-term MALDI
sample archiving in 220 °C freezers was possible without
suffering any loss of analytical performance and information
when the samples were re-analyzed after these storage con-
ditions. The two main advances provided by liquid MALDI,
however, are the extremely robust and stable ion yield as
demonstrated by Palmblad et al. (38) and the recently discov-
ered possibility of generating ESI-like multiply charged ions
under atmospheric pressure (39). It was shown that with the
robust and stable ion yield much higher reproducibility is
achievable, resulting in low ion signal fluctuations similar to
nanoESI and standard deviations for database search results
of protein digest replicate analyses at around 5-10% or less
compared with 10-25% or more for solid MALDI, particularly
for low-purity samples (40). The second main advance, the
production of ESI-like multiply charged ions, allows the use
of high-performing hybrid mass analyzers with a typically
small m/z range as found in Q-TOF and hybrid orbitrap
instruments. It therefore results in post-source MS/MS pep-
tide sequencing in the same way as for ESI-generated pep-
tide ions, without any indication of a difference in fragmenta-
tion related to the origin of these ions (37, 39) – for in-source
fragmentation, however, fragment ion generation appears to
be dependent on the exact matrix being used and therefore
different to ESI (41). This new and unique feature in MALDI
MS was exploited by Hale et al. for identifying discriminative
protein fragments in liquid AP-MALDI MS profiling for the
accurate detection of bovine mastitis from extremely small
amounts of milk (30). Interestingly, liquid AP-MALDI MS profil-
ing on a Q-TOF instrument also revealed another advantage of
this MALDI/Q-TOF combination as it showed that small mole-
cules such as metabolites and lipids can be effectively co-
detected together with larger peptides and proteins in a single
spectrum (30, 42). In conventional (vacuum) MALDI MS using
axial TOF instruments usually only one or the other can be
effectively analyzed because of the difference in acquisition
modes employed for small molecules (high-resolution reflec-
tron mode) and larger molecules such as proteins (linear mode
with increased laser energy, and thus extremely high amounts
of ions in the lower m/z range, which are normally suppressed
before and/or at the detection step). Thus, liquid AP-MALDI
MS provides a greater range of accessible analytes that can
be detected in the same spectrum, making comprehensive
biomolecular profiling by MALDI MS potentially more powerful
than that offered by current methods using conventional (solid-
state and vacuum) MALDI MS profiling as available in commer-
cial MALDI MS biotyping platforms.
The potential of these new developments in MALDI in
addition to the well-known fundamental advantages of a
laser-based analytical method (e.g. in speed) have so far
attained little attention. With these new step changes being
made in MALDI MS-based methods it now seems to be a
good time to (re)consider extreme high-speed and large-
scale proteomics with all its potential in gaining additional
information for biological systems analysis and disease
diagnostics.
In this context it has to be noted that the recent large influx
of new acronyms for supposedly novel (laser) ionization tech-
niques, without scrutinizing the technique’s analytical useful-
ness and in many cases its novelty, let alone the need for
creating a new acronym, has not been helpful. In fact, it con-
fuses the field and makes it difficult to find true advances. As
a result, many groups are deterred from further exploring
truly novel and advantageous developments in this area.
Finally, nonMS proteomic tools such as immunoassays
and enzymatic activity assays seem to be in many cases
good alternatives for large-scale and high-speed proteomics
(43, 44). In virtually all cases, however, the highly targeted na-
ture of these assays and the time often needed for the nec-
essary reactions and readouts disqualify these methods as
serious competitors. In many cases, issues with respect to
specificity, traceability and development costs are further
aspects that render them ultimately uncompetitive. Neverthe-
less, it must be noted that the one strong advantage of such
methods is the possibility of point-of-care and in-field appli-
cations, which is still a weak point for all current MS-based
(prote)omic analyses.
In conclusion, after the advent of modern MS in the omics
and its stellar rise as the analytical method of choice, MS has
further advanced in areas of its obvious strength such as
high sensitivity and specificity in biomolecular detection,
mainly as a result of further improvements in mass ana-
lyzers (including greater mass measurement resolution and
accuracy), sample preparation methods and separation/
fractionation techniques. ESI-based methods have been for
most of these advances the obvious choice and at the cen-
ter for further improvements. As a direct result some areas
such as high-speed and large-scale (prote)omic analysis of
large numbers of biological samples have been challenging
and therefore somewhat neglected. There have been
advances in these areas however and it is now feasible to
undertake (prote)omic analysis of millions of samples at
much higher speed using nonESI-based methods. These
analyses might never provide the depth of LC-ESI MS/MS
with all its improvements made over decades (e.g. nanoESI,
UHPLC, multiplex labeling, . . .) but will be able to provide
some depth in biomolecular detection, partially benefitting
from the same MS hardware that also improved ESI-based
analyses. Importantly, these nonESI-based methods can
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offer the speed and scalability that is still missing to satisfy
the requirements for population-wide and longitudinal sample
collections. Achieving the latter will not only help the advance-
ment of personalized and precision medicine but also provide
invaluable data regarding population-wide and environment-/
time-specific changes of the proteome. Although critical voices
might argue that the biomolecular coverage will never be as
great as with LC-ESI-based MS analyses, it would seem to be
grossly negligent to ignore the additional richness of the omic
and system information that large sample sets collected over
various dimensions can offer. Even if it will never be possible
to analyze the entire proteome by these methods – as will
probably never be possible with an ESI-based MS method ei-
ther – there are now clear indications that the analytical depth
is sufficient to pursue (prote)omic analyses at the speed of
thousands or more samples per day (34, 37). The analysis of a
million samples per day on a single MS platform is also well
within the capabilities of laser-based ionization techniques,
though here it remains to be seen whether more than a hun-
dred biomolecular species can be analyzed at this speed. Early
data obtained by the laser-based method of liquid AP-MALDI
using high-performing hybrid mass analyzers are encouraging
and indicate that analysis at this speed and depth are entirely
possible in the foreseeable future (34). Importantly, the analyti-
cal depth, signal robustness and sample flexibility of this new
approach is well beyond early MS profiling methods using con-
ventional, solid-state MALDI on axial TOF mass analyzers.
These extremely fast analyses would then be able to fill many
of the gaps in the field of proteomics that can currently only be
served with severe limitations by the commonly employed but
much slower ESI-based proteomic tools.
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